BioNTech shares fall more than 10% in pre-market trading
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Ten Data August 28 | BioNTech SE (BNTX.US) is down over 10% in pre-market trading, quoted at $99.97. The company announced the termination of Phase 2 Cevumeran cancer immunotherapy trial.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Yum! Brands' Taco Bell, Americana Restaurants Partner for UAE Expansion
MT newswire•2026/08/28 15:19
Canada Nickel Company Raised C$21 Million Via Non-Brokered Private Placement
MT newswire•2026/08/28 15:19
Affirm's Fiscal Q4 Provisions Due to Product, Funding Mix, Not Credit Deterioration, BofA Says
MT newswire•2026/08/28 15:17
Crypto prices
More
Bitcoin
BTC
$79,334.2
-1.40%
Ethereum
ETH
$2,504.37
-0.60%
Tether USDt
USDT
$1
+0.01%
BNB
BNB
$703.04
-1.12%
XRP
XRP
$1.43
-2.39%
USDC
USDC
$1.0000
-0.00%
Solana
SOL
$107.08
-0.14%
TRON
TRX
$0.3406
+0.87%
Hyperliquid
HYPE
$84
-0.90%
Zcash
ZEC
$811.84
+2.04%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now